Solid Biosciences Inc. SLDB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$56.74M-44.4% | -$49.79M-16.9% | -$45.78M-39.9% | -$39.48M-57.5% | -$39.28M-61.6% | ||
| $395K-2.9% | $467K-4.3% | $376K-7.2% | $386K-68.7% | $407K+24.5% | ||
| $5.15M+54.2% | $6.5M+70.1% | $3.93M+31.2% | $3.15M+50.3% | $3.34M+107% | ||
| -$47.23M-48.3% | -$53.56M-80.7% | -$33.47M-41.2% | -$37.41M-74.3% | -$31.85M-26.4% | ||
| $165K+31.0% | $565K+177% | $85K+467% | $377K+31.8% | $126K-15.4% | ||
| $44.76M+263% | —— | -$45.27M-312% | -$32.73M-532% | -$27.46M+28.6% | ||
| $0-100% | $203K+58.6% | $243K+102% | $142K-36.9% | $135K— | ||
| $239.03M+26.0% | $5.14M-25.9% | $1.18M-63.9% | $0-100% | $189.73M+76.9% | ||
| $236.56M+81.4% | -$1.4M-109% | -$77.57M-147% | -$71.75M— | $130.42M+199% | ||
| -$47.4M-48.2% | -$54.12M-81.3% | -$33.56M-41.5% | -$37.79M-73.7% | -$31.98M-26.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.